Open an account

Nexgel

NXGL · NASDAQ

$5.33−$0.47 (−8.10%)TodayMarket closed ·
Prev close $5.80

About NXGL

NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises is comprised of the CGN JV used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George. The company also holds a portfolio of regenerative biomaterials which include Biovance, Biovance 3L, Natalin, and others.

Employees
19
Headquarters
Langhorne, Pennsylvania
Listed
Dec 22, 2021
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
nexgel.com

NXGL key statistics

Market cap
16.38M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
228.65K
Volume
28.73K
Open price
$5.80
High today
$5.80
Low today
$4.50
52 Week high
$57.00
52 Week low
$3.00

Nexgel (NXGL) at a glance

Nexgel (NXGL) last traded at $5.33, with a market cap of 16.38M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $4.50 and $5.80. The current price is 18.4% above the day's low and 8.1% below its high.

Volume so far is 28.73K shares, below the average of 228.65K shares a day.

Over the past year Nexgel has ranged from $3.00 to $57.00, and now sits 4% of the way up that range.

Nexgel met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$7.40 per share against an estimate of -$2.45.

The average analyst price target is $2.04, 61.7% below the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $2.04
Low
$2.02
Now
$5.33
High
$2.10

NXGL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 6.9% on average.

  1. Q3 FY24: reported -$0.11 per share against an estimate of -$0.102
  2. Q4 FY24: reported -$0.11 per share against an estimate of -$0.102
  3. Q1 FY25: reported -$0.09 per share against an estimate of -$0.102
  4. Q2 FY25: reported -$0.09 per share against an estimate of -$0.0714
  5. Q3 FY25: reported -$0.08 per share against an estimate of -$0.0816
  6. Q4 FY25: reported -$0.12 per share against an estimate of -$0.0918
  7. Q1 FY26: reported -$2.20 per share against an estimate of -$1.43
  8. Q2 FY26: reported -$7.40 per share against an estimate of -$2.45

NXGL news

  • Caroline Ryan

    Deal Dispatch: MunichRe Buys At-Bay, Mavis Tire Closes Pep Boys Purchase, Werewolf Merges With Ambros

  • Avi Kapoor

    Gold Gains 1%; US Home-Builder Sentiment Edges Higher In August

  • Avi Kapoor

    Dow Falls 150 Points; NY Empire State Manufacturing Index Rises In August

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseGlobe Newswire

    NEXGEL to Present at Planet MicroCap Conference Las Vegas on June 16th –18th

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releaseGlobe Newswire

    NEXGEL to Present at the LD Micro Main Event XIX Conference on October 19-21

Similar companies

Companies in the same industry as Nexgel

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.